SUTTI, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 1.914
NA - Nord America 1.726
AS - Asia 1.222
SA - Sud America 142
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.068
Nazione #
US - Stati Uniti d'America 1.673
RU - Federazione Russa 467
SG - Singapore 379
IE - Irlanda 314
IT - Italia 281
DE - Germania 280
CN - Cina 221
HK - Hong Kong 187
VN - Vietnam 160
SE - Svezia 155
BR - Brasile 109
FR - Francia 103
UA - Ucraina 95
IN - India 75
FI - Finlandia 61
GB - Regno Unito 54
KR - Corea 46
BD - Bangladesh 37
ID - Indonesia 34
CA - Canada 27
PL - Polonia 27
BJ - Benin 25
BE - Belgio 21
AR - Argentina 19
NL - Olanda 19
TR - Turchia 19
MX - Messico 18
JP - Giappone 17
ZA - Sudafrica 12
AT - Austria 10
ES - Italia 8
IQ - Iraq 8
CZ - Repubblica Ceca 7
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
DZ - Algeria 4
IR - Iran 4
LT - Lituania 4
MA - Marocco 4
NG - Nigeria 4
PY - Paraguay 4
EC - Ecuador 3
PH - Filippine 3
SA - Arabia Saudita 3
VE - Venezuela 3
AU - Australia 2
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
NP - Nepal 2
SN - Senegal 2
TN - Tunisia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.068
Città #
Dublin 305
San Jose 242
Hong Kong 186
Jacksonville 159
Singapore 145
Ashburn 123
Council Bluffs 101
Dearborn 82
Beijing 66
Munich 65
Chandler 59
Los Angeles 53
Moscow 50
Ho Chi Minh City 48
Seoul 45
Lauterbourg 42
Novara 42
Wilmington 42
Milan 37
New York 37
Hanoi 34
Lawrence 33
Princeton 33
Turin 33
Jakarta 28
Santa Clara 28
Piemonte 27
Buffalo 26
Cotonou 25
Dallas 25
Ann Arbor 22
Bremen 21
Brussels 20
Grafing 20
St Louis 20
Strasbourg 20
Warsaw 20
Frankfurt am Main 19
Dong Ket 18
Helsinki 18
London 18
Brooklyn 16
Monmouth Junction 13
Nuremberg 13
San Mateo 13
Andover 12
Falkenstein 12
Houston 12
Orem 12
The Dalles 12
Tokyo 12
Amsterdam 11
Denver 11
Guangzhou 11
Stockholm 11
Atlanta 10
Chennai 10
Kocaeli 10
Mumbai 10
Phoenix 10
Poplar 10
São Paulo 10
Boston 9
Hangzhou 9
Johannesburg 9
Nanjing 9
Rome 9
Tianjin 9
Toronto 9
Vercelli 9
Haiphong 8
Mexico City 8
Montreal 8
Odalengo Grande 8
Kunming 7
Mülheim 7
Redondo Beach 7
Turku 7
Woodbridge 7
Assago 6
Chicago 6
Columbus 6
Gdynia 6
Leawood 6
Manchester 6
Vienna 6
Ankara 5
Augusta 5
Baghdad 5
Berlin 5
Brno 5
Charlotte 5
Da Nang 5
Genoa 5
Bulandshahr 4
Can Tho 4
Cassano Magnago 4
Fairfield 4
Norwalk 4
Querétaro 4
Totale 2.923
Nome #
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 174
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 149
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation 146
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice 142
Role of Balanced Involvement of the ICOS/ICOSL/Osteopontin Network in Cutaneous Wound Healing 141
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury 141
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis 139
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis 139
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH) 138
Adaptive immunity: an emerging player in the progression of NAFLD 136
From MASLD to HCC: What's in the middle? 135
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 133
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 129
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 122
CYP2E1 autoantibodies in liver diseases 113
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update 113
Is there a role for adaptive immunity in nonalcoholic steatohepatitis? 111
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 109
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. 109
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 107
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein 107
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 106
Notch signaling and progenitor/ductular reaction in steatohepatitis. 105
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 102
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 100
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 98
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 96
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 96
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts 94
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 94
Conformational anti-cytochrome P4502E1 auto-antibodies contributes to necro-inflammatory injury in chronic hepatitis C 91
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 90
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 89
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 89
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 88
Interplay between oxidative stress and steatosis in the progression of Hepatitis C 88
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 88
Liver inflammation and regeneration in drug-induced liver injury: Sex matters! 87
Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry 86
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 83
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease 82
NF-kB1 deficiency stimulates the progression of nonalcoholic steatohepatitis (NASH) in mice by promoting NKT-mediated responses 81
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma 73
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 72
Immune response against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers 71
Editorial: Inflammatory responses on the road from NASH to HCC: pathogenic mechanisms and possible therapeutic strategies 67
Inflammatory processes involved in NASH-related hepatocellular carcinoma 65
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses 60
ICOSL: more than a trigger of ICOS function 44
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 21
Dietary Fructose Alters Duodenal Mucin Glycosylation and Mucus Production in High-Fat Diet-Fed Mice 14
Totale 5.153
Categoria #
all - tutte 24.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022312 10 19 17 10 17 31 35 7 19 24 49 74
2022/2023690 75 31 39 14 49 66 31 21 316 2 33 13
2023/2024242 18 21 13 3 35 7 50 5 9 5 43 33
2024/2025729 8 8 45 12 31 64 102 76 117 59 26 181
2025/20262.474 106 116 149 296 260 155 371 369 173 251 139 89
Totale 5.153